Panax notoginsenoside composition
A panax notoginsenoside composition for patients having coronary heart disease, high blood pressure, high blood fat, and high cholesterol, consists of 41% by weight of panax notoginsenoside powder extracted from panax notoginseng (Burk.) F. H. chen ex C. Chow et al, 0.5% by weight of beeswax, 58.48% by weight of peanut oil, and 0.02% by weight of BHT.
Patent Number: 6500468 | Patent Date: 12/31/2002
Breviscapinum and extracting process thereof from erigeron breviscapus
An extracting process for extracting breviscapinum from erigeron breviscapus, wherein the breviscapinum has a chemical structure of 4',5,6-trishydroxyflavone-7-glucuronide that can increases cerebral blood flow for significantly decreasing cerebrovascular resistance; raises permeability of blood-brain barrier, increases nutritional blood flow of myocardium; raises immune function of body macrophage cell and counteraction against blood and oxygen depletion induced by hypophyseal pitutrin and thrombocyte agglutination induced by adenosine diphespate inhibiting internal thrombosis and promoting activity of cellulose dissolution; and increases peripheral and coronary bleed flow, effective for sequelas induced by cerebrovascular accident: palsy, coronary heart disease and angina pectoris.
Patent Number: 6084080 | Patent Date: 07/04/2000
